OTCEquity is a premier site for updated news and financial information regarding penny stocks and small cap companies. We offer a free newsletter, articles about penny stock trading, otc bulletin board analytical data and original news stories about the penny stock companies you are interested in.

Registration to our newsletter is FREE, Join today by entering your email below!

Healthcare Stocks Climbing: ProPhase Labs, Inc., A.P. Pharma, Inc., AspenBio Pharma, Inc., SuperGen, Inc., Pressure BioSciences, Inc.

Bookmark and Share

While Healthcare stocks took a slight hit on Tuesday, falling 0.35% on the day, there were several NASDAQ stocks that had plenty of life with ProPhase Labs, Inc. (NASDAQ: PRPH) showing the biggest surge posting a 32.08% increase to close at 1.40. Trading volume was nearly 10x its average on Tuesday and shares are moving ahead of the 50-day moving average of 1.23 and closing in on the 200-day moving average of 1.64.

A.P. Pharma, Inc. (NASDAQ: APPA) was also the picture of health on Tuesday as shares jumped 28.07% on the day to close at 0.73. Shares in the specialty pharmaceutical company traded at more than 15x its average volume and are now well ahead of the 50-day moving average of 0.59 but remain behind the 200-day moving average of 0.94.

Following news that AspenBio Pharma, Inc. (NASDAQ: APPY) had initiated manufacturing of its AppyScore™ cassette-based test system to be used in further validation and verification testing of AppyScore — a novel, blood-based diagnostic test designed to aid emergency department physicians in the difficult challenge of evaluating patients suspected of having appendicitis shares in the company moved up 25.19% to close at 0.7136. APPY posted a massive volume for the day with more than 20x its average moving hands.

SuperGen, Inc. (NASDAQ: SUPG) shares pushed forward 21.03% to close at 2.82 on Tuesday following yesterday’s news that their financial outlook for 2010 was better than expected. With strong sales of its drug Dacogen, it was raising its 2010 royalty-revenue estimate from the product to $49 million to $52 million, up from $44 million to $48 million. Shares are now comfortably ahead of its 50-day moving average of 2.14 and 200-day moving average of 2.51.

Pressure BioSciences, Inc. (NASDAQ: PBIO) saw shares move up 16.13% on Tuesday to close at 1.80 after they announced that two scientific presentations have provided further evidence that pressure cycling technology offers an improved method for the extraction of DNA in the analysis of forensic evidentiary samples. With the news shares traded at nearly 30x their volume average and during that activity PBIO set a 52-week high of 2.29.

This entry was posted in NASDAQ, News and tagged , , , , , , , , , , , , , , . Bookmark the permalink.

Bookmark and Share

Leave a Reply